Quantcast
Last updated on April 17, 2014 at 12:46 EDT

Latest genotype Stories

2012-03-13 02:30:00

HUDDINGE, Sweden, March 13, 2012 /PRNewswire/ -- - Study in previous non-responder Hepatitis C genotype-1 infected patients - Study in Hepatitis C genotype-4 infected patients MedivirAB (OMX: MVIR) a research based specialty pharmaceutical company focused on infectious diseases announces that its oral, once daily investigational protease inhibitor TMC435, developed by Janssen Pharmaceuticals for the treatment of Hepatitis C virus (HCV), has commenced...

2012-03-07 11:00:53

Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer. Both studies found that CYP2D6 genotypes that were indicative of reduced activity of enzymes that metabolize tamoxifen did not predict...

2012-02-21 11:40:16

A towering $60,000 bill, a year of fierce, flu-like symptoms and a running risk of depression are among the possible costs of two new hepatitis C treatments. But according to Stanford University health policy researchers, they might be worth it. Using a computer model of hepatitis C disease – which accounts for different treatments, outcomes, disease stages and genetics – a research team led by Jeremy Goldhaber-Fiebert, PhD, found that new triple-therapies for genotype-1...

2012-01-25 07:00:00

ADA, Mich., Jan. 25, 2012 /PRNewswire/ -- Weight loss is perhaps the most common New Year's resolution made and likely the most difficult to keep. Amway North America offers the NUTRILITE(®) Weight Management Program, which includes a genetic test that helps individuals find their genotype-matched diet, and offers weight management plans matched to that gene test's results. To view the multimedia assets associated with this release, please click:...

2012-01-19 10:23:00

Researchers targeted the type of hepatitis C most common in the United States, results reported in New England Journal of Medicine ANN ARBOR, Mich., Jan. 19, 2012 /PRNewswire-USNewswire/ -- A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist. The study, published Jan. 19 in the New England Journal of...

2012-01-19 11:31:56

Researchers targeted the type of hepatitis C most common in the United States, results reported in New England Journal of Medicine A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist. The study, which will be published Jan. 19 in the New England Journal of Medicine, focused on hepatitis C genotype 1, which is...

2011-12-28 07:54:24

Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA. Clopidogrel is an antiplatelet...

2011-12-16 13:59:19

Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease. Now, researchers have found that different variants of NACP-Rep1 and its interaction with the microtubule-associated protein tau (MAPT) H1 haplotype can influence the speed of clinical...

2011-12-02 06:30:00

HUDDINGE, Sweden, December 2, 2011 /PRNewswire/ -- Medivir AB (OMX:MVIR), the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Tibotec Pharmaceuticals, has entered into an agreement with Bristol-Myers Squibb Company (NYSE:BMY). TMC435, a once daily NS3/4A protease inhibitor (PI) for the treatment of genotype-1 chronic hepatitis C virus (HCV) infection will...

2011-11-15 19:27:08

There´s definitely something to be said for first impressions. New research from the University of California, Berkeley, suggests it can take just 20 seconds to detect whether a stranger is genetically inclined to being trustworthy, kind or compassionate. The findings reinforce that healthy humans are wired to recognize strangers who may help them out in a tough situation. They also pave the way for genetic therapies for people who are not innately sympathetic, researchers said....